Skip to main content
Caplight Logo









Jiangsu Trautec Medical Technology Co., Ltd.

Jiangsu Trautec Medical Technology Co., Ltd.

Private
ChangzhouHealthcare & Life Scienceshttps://trautec.us/

Last Round

Series B

Sep 16, 2023

Total Funding Raised

$56.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Jiangsu Trautec Medical Technology Co., Ltd. is a biotechnology company that develops and produces synthetic recombinant human collagen (SRHC) for applications in skincare, medical dressings, and aesthetic treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Medical Devices, Fashion & Beauty

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

recombinant human collagenSRHCanimal-free collagenvegan collagenbiomaterialssynthetic biologysynbioregenerative medicineCDMOcontract manufacturingmicrobial fermentationmedical aestheticsPDRNbiomanufacturingskincare ingredients

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jiangsu Trautec Medical Technology Co., Ltd. Comparables

Compare Jiangsu Trautec Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Jiangsu Trautec Medical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Jiangsu Jland Biotech Co., Ltd.
91%
Shanxi Jinbo Bio-Pharmaceutical Co., Ltd.
84%
Geltor
82%

Jiangsu Trautec Medical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 16, 2023
Series AAug 10, 2022

Jiangsu Trautec Medical Technology Co., Ltd. Investors

Notable investors and investment history

Jiangsu Trautec Medical Technology Co., Ltd. investors
InvestorRounds
Boyu CapitalSeries A
CDH BaifuSeries A
L CattertonSeries B
CLSA Capital PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors increased 418% MoM.

  • Apr 22, 2026

    Monthly visitors increased 57% MoM.

Jiangsu Trautec Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Jiangsu Trautec Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Jiangsu Trautec Medical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChangzhou
Employee Range9
Year Founded2015
Last FundingSep 16, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?